$0.661
+0.033 (+4.92%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
RDHL 相似图表分析预测
Alphio's RDHL stock price prediction model matches the current Redhill Biopharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.69 (+3.74%). The 1-week path is $0.72 (+8.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Redhill Biopharma Ltd 股票吗？
Redhill Biopharma Ltd (RDHL) is currently not a strong buy due to its high RSI of 72.825, indicating overbought conditions, and a forward P/E ratio of 1428.57, which suggests that the stock is highly overvalued compared to its earnings potential. While there is potential for growth due to the recent FDA designations, the company has a significant risk with a current ratio of 0.54, indicating potential liquidity issues.
RDHL 股价于 Friday 收于 $0.66，此前上涨 +4.92%
Redhill Biopharma Ltd (RDHL) last closed at $0.661, gaining +4.92%. These facts feed the 1-day and 1-week RDHL price prediction above.
分析师一致预期
Redhill Biopharma Ltd（RDHL）：买入 4、持有 0、卖出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Redhill Biopharma Ltd（RDHL）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似图表形态
近期走势与 RDHL 最接近的股票，按相似度排序。
RDHL 季节性分析
Historically the probability of a positive August return for RDHL is 0.00%. January offers the highest probability of a positive month at 44.26%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。